The quadrivalent flu vaccine is designed to protect against four different flu viruses; two influenza A viruses and two influenza B viruses. Quadrivalent seasonal human Influenza vaccine (Quadrivalent-FluPak® ( is manufactured under GMP standards and  has approval of  Iranian NRA under supervision of WHO. Quadrivalent-FluPak® is an egg base inactivated split virion vaccine without thiomersal, which presented in single dose form in prefilled syringe 0.5 ml. and  present in market since 2018.

  • Factory:

    No.96, Noavari 9th st., Pardis Technology Park, Tehran-IRAN
    Tel: +9821 76250681-4 Fax: +9821 76250680

  • head office

    3rd Floor, No. 30, Eskandari – Shomali st., Azadi ave.,
    Tehran – Iran
    Postal code: 149933941
    Tel: + 98 21 66949644 (6lines)
    Fax: +98 21 66949643

  • Viromed Laboratory ( 3rd Branch)

    No. 1023, Next To Tamin Ejtemaei Clinic, Shohada St., Rasht, Iran
    Postal Code: 4176915168
    Tel: 0131- 8853410
    Fax: 0131- 8853410